New research in biomechanics measures the impact of head-first, hand-first and feet-first diving and the likelihood of injury at different diving heights.
A study suggests boosting “naturally-produced” antibodies in mothers may enhance infants’ immunity against bacterial pathogens that cause infectious gastrointestinal diseases.
A diverse group of students and recent graduates representing Cornell’s four contract colleges has been selected to receive the 2023 State University of New York Chancellor’s Award for Student Excellence.
The study suggests that a unique set of regulatory networks controlled by neurons in the gut may be viable targets for future drug therapies to combat chronic inflammatory diseases including asthma, allergy and inflammatory bowel disease.
Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia, according to a preclinical study by investigators at Weill Cornell Medicine.
In 1998, Professor Steven Strogatz and then-student Duncan Watts, Ph.D. '97, published a model that launched the field of network science – the results of which are ubiquitous in today’s world.
Globally, by the end of this century low-income cattle farmers in poor countries may face financial loss between $15 to $40 billion annually, due to looming climate change.
Researchers at Weill Cornell Medicine have developed a pre-clinical model of the leading cause of central vision loss in older individuals, dry age-related macular degeneration, and used it to identify new treatment modalities and drug targets.
New research found that establishing complete trauma care programs accessible to 100% of road injury victims could save the lives of 200,000 people annually.
Abnormalities in a type of brain cell called astrocytes may play a pivotal role in causing some behavioral symptoms of autism spectrum disorders, according to a preclinical study by Weill Cornell Medicine investigators.